These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5803088)

  • 41. Nosocomial multiply resistant Providencia stuartii: a long-term outbreak with multiple biotypes and serotypes at one hospital.
    Kocka FE; Srinivasan S; Mowjood M; Kantor HS
    J Clin Microbiol; 1980 Feb; 11(2):167-9. PubMed ID: 7358840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of Proteus species in urinary tract infections in a regional hospital in Trinidad.
    Orrett FA
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):438-42. PubMed ID: 10418178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Significance of laboratory data in the choice of antibiotics for the treatment of infections caused by microbes of the genus Proteus].
    Kuznetsova SM; Fomina IP
    Antibiotiki; 1969 May; 14(5):422-6. PubMed ID: 4891716
    [No Abstract]   [Full Text] [Related]  

  • 44. [Bacterial resistance in the infections from gram-negative bacilli in a long-term hospital (author's transl)].
    Barbieri R; Cespa A; Curti E; Vigoni A
    Quad Sclavo Diagn; 1979 Jun; 15 Suppl 1():691-9. PubMed ID: 400255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Proteus infections].
    Sorice F
    G Mal Infett Parassit; 1968 Oct; 20(10):896-903. PubMed ID: 5733971
    [No Abstract]   [Full Text] [Related]  

  • 46. The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for the urinary tract.
    Adegbola RA; Old DC; Senior BW
    J Med Microbiol; 1983 Nov; 16(4):427-31. PubMed ID: 6139485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report.
    Savini V; Catavitello C; Talia M; Di Berardino F; Manna A; Balbinot A; Febbo F; Carlino D; Fioritoni F; Di Bonaventura G; D'Antonio D
    Int J Low Extrem Wounds; 2008 Jun; 7(2):99-101. PubMed ID: 18483010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antibiotic resistance of community-acquired uropathogenic Enterobacteriaceae isolated in Sfax (Tunisia)].
    Smaoui S; Abdelhedi K; Marouane C; Kammoun S; Messadi-Akrout F
    Med Mal Infect; 2015 Aug; 45(8):335-7. PubMed ID: 26362517
    [No Abstract]   [Full Text] [Related]  

  • 49. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidemiological studies of increasing appearances of Proteus inconstans (Providencia stuartii) infections (author's transl)].
    Kopf PO; Freitag V; Caselitz FH; Kolbe S
    Immun Infekt; 1980; 8(3):96-100. PubMed ID: 7461700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Sensitivity to some antibacterial agents, of the microbial flora isolated from patients with infections of the urinary tract in the years 1964-1967].
    Diana L; Romano M; Perin G
    Ig Mod; 1968; 61(5):292-315. PubMed ID: 4889607
    [No Abstract]   [Full Text] [Related]  

  • 52. [Urinary tract infections: bacteriology, treatment, and antibody- coated bacteria].
    Rahal K
    Arch Inst Pasteur Alger; 1988; 56():79-94. PubMed ID: 3077241
    [No Abstract]   [Full Text] [Related]  

  • 53. [Bacterial replacements in urinary tract infections and clinical observations].
    Iwata S
    Iryo; 1972 Jan; 26(1):26-32. PubMed ID: 4554980
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of endocarditis due to Proteus species: a literature review.
    Kalra A; Cooley C; Tsigrelis C
    Int J Infect Dis; 2011 Apr; 15(4):e222-5. PubMed ID: 21237686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
    Chen CY; Chen YH; Lu PL; Lin WR; Chen TC; Lin CY
    J Microbiol Immunol Infect; 2012 Jun; 45(3):228-36. PubMed ID: 22572004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The localization of urinary tract infection by ureteric catheterization.
    Eykyn S; Lloyd-Davies RW; Shuttleworth KE; Vinnicombe J
    Invest Urol; 1972 Jan; 9(4):271-5. PubMed ID: 4550877
    [No Abstract]   [Full Text] [Related]  

  • 57. The changing nature of bacterial infections. Patterns of hospital infection.
    Derrington AW
    Med J Aust; 1970 Jun; 1():Suppl:3-5. PubMed ID: 4916056
    [No Abstract]   [Full Text] [Related]  

  • 58. Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.
    Endimiani A; Luzzaro F; Brigante G; Perilli M; Lombardi G; Amicosante G; Rossolini GM; Toniolo A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2598-605. PubMed ID: 15980325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Urinary tract infections - bacteriology and pathogenic factors (author's transl)].
    Sietzen W
    Urologe A; 1981 Jan; 20(1):10-3. PubMed ID: 7013229
    [No Abstract]   [Full Text] [Related]  

  • 60. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.
    Hawkey PM
    J Antimicrob Chemother; 1984 Mar; 13(3):209-26. PubMed ID: 6373713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.